MAP2MAG-76K
MILLIPLEX® Mouse Acute Phase Magnetic Bead Panel 2 - Cardiovascular Disease Multiplex Assay
The analytes available for this multiplex kit are: Adipsin, Alpha-1 Acid Glycoprotein (AGP), Alpha-2 Macroglobulin (A2M), C-Reactive Protein, Haptoglobin, SAP.
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
About This Item
Codice UNSPSC:
12161503
eCl@ss:
32161000
NACRES:
NA.84
Prodotti consigliati
Livello qualitativo
Reattività contro le specie
mouse
Produttore/marchio commerciale
Milliplex®
assay range
accuracy: 99.2-128.2%
sensitivity: 0.001-7.495 ng/mL
standard curve range: 0.001-0.5 ng/mL
(AGP)
standard curve range: 0.005-4.0 ng/mL
(Adipsin)
standard curve range: 0.014-10 ng/mL
(CRP)
standard curve range: 0.549-400 ng/mL
(Haptoglobin)
standard curve range: 13.717-10,000 ng/mL
(SAP)
standard curve range: 6.858-5000 ng/mL
(A2M)
inter-assay cv: <15%
intra-assay cv: <10%
tecniche
multiplexing: suitable
Metodo di rivelazione
fluorometric (Luminex xMAP)
Condizioni di spedizione
wet ice
Descrizione generale
Acute phase proteins are a class of proteins whose circulating concentrations increase (positive acute phase proteins) or decrease (negative acute phase proteins) in response to inflammation. This response is called the acute phase reaction or acute phase response. In recent years several new acute phase proteins have been identified, some of which are secreted from adipose tissue.
MILLIPLEX® Mouse Acute Phase Magnetic Bead Panel 2 is a 6-plex kit to be used for the simultaneous quantification of any or all of the following analytes in mouse serum or plasma samples, mouse tissue extract, or cell/tissue culture supernatant samples: Adipsin (Complement Factor D), Alpha-1 Acid Glycoprotein (AGP), C-Reactive Protein (CRP), Haptoglobin (HPTGN), Alpha-2 Macroglobulin (A2M) and Serum Amyloid Protein/Pentraxin-2 (SAP). This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.
The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.
Panel Type: Cardiovascular
MILLIPLEX® Mouse Acute Phase Magnetic Bead Panel 2 is a 6-plex kit to be used for the simultaneous quantification of any or all of the following analytes in mouse serum or plasma samples, mouse tissue extract, or cell/tissue culture supernatant samples: Adipsin (Complement Factor D), Alpha-1 Acid Glycoprotein (AGP), C-Reactive Protein (CRP), Haptoglobin (HPTGN), Alpha-2 Macroglobulin (A2M) and Serum Amyloid Protein/Pentraxin-2 (SAP). This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.
The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.
Panel Type: Cardiovascular
Specificità
Cross Reactivty
Antibody pairs in the panel are specific and demonstrate no cross-reactivity (<0.1%) with
other analytes in the panel.
Antibody pairs in the panel are specific and demonstrate no cross-reactivity (<0.1%) with
other analytes in the panel.
Applicazioni
- Analytes: α-1, Acid Glycoprotein (AGP), α-2 Macroglobulin (A2M), Adipsin (Factor D), C-Reactive Protein (CRP), Haptoglobin, Serum Amyloid P (SAP)
- Recommended Sample Type: Mouse serum, plasma or cell/tissue culture supernatants lysates
- Recommended Sample Dilution: 25 μL per well of 1:20,000 diluted serum or plasma; cell/tissue culture samples may require dilution in appropriate control medium
- Assay Run Time: Overnight (16-22 hours) at 2-8°C
- Research Category: Cardiovascular
- Research Subcategory: Metabolism
Caratteristiche e vantaggi
Design your multiplex kit by choosing available analytes within this panel.
Note legali
Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp
Avvertenze
Danger
Indicazioni di pericolo
Classi di pericolo
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
Organi bersaglio
Respiratory Tract
Codice della classe di stoccaggio
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
Certificati d'analisi (COA)
Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
R B Kostogrys et al.
The journal of nutrition, health & aging, 19(7), 710-718 (2015-07-22)
Low Carbohydrate High Protein diet represents a popular strategy to achieve weight loss. The aim of this study was to characterize effects of low carbohydrate, high protein diet (LCHP) on atherosclerotic plaque development in brachiocephalic artery (BCA) in apoE/LDLR-/- mice
Edward O List et al.
Molecular endocrinology (Baltimore, Md.), 27(3), 524-535 (2013-01-26)
GH receptor (GHR) gene-disrupted mice (GHR-/-) have provided countless discoveries as to the numerous actions of GH. Many of these discoveries highlight the importance of GH in adipose tissue. For example GHR-/- mice are insulin sensitive yet obese with preferential
Damir Nizamutdinov et al.
Scientific reports, 7, 40112-40112 (2017-01-21)
Annually, there are over 2 million incidents of traumatic brain injury (TBI) and treatment options are non-existent. While many TBI studies have focused on the brain, peripheral contributions involving the digestive and immune systems are emerging as factors involved in
Nigel Davies et al.
Molecular therapy. Nucleic acids, 24, 369-384 (2021-04-20)
Lipid nanoparticles (LNPs) are the most clinically advanced delivery system for RNA-based drugs but have predominantly been investigated for intravenous and intramuscular administration. Subcutaneous administration opens the possibility of patient self-administration and hence long-term chronic treatment that could enable messenger
Susan J Zunino et al.
The British journal of nutrition, 108(5), 900-909 (2011-11-10)
Obesity is a strong risk factor for the development of CVD, hypertension and type 2 diabetes. The overall goal of the present pilot study was to feed strawberries, in the form of freeze-dried powder, to obese subjects to determine whether
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.